Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the hepatic component of metabolic syndrome. Despite the beneficial health effects of cardamom on dyslipidemia, hepatomegaly, and fasting hyperglycemia, no previous human study has been conducted on the efficacy of cardamom in NAFLD. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales: Daneshi-Maskooni, Milad, Keshavarz, Seyed Ali, Qorbani, Mostafa, Mansouri, Siavash, Alavian, Seyed Moayed, Badri-Fariman, Mahtab, Jazayeri-Tehrani, Seyed Ali, Sotoudeh, Gity
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156864/
https://www.ncbi.nlm.nih.gov/pubmed/30263038
http://dx.doi.org/10.1186/s12986-018-0297-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156864/
https://www.ncbi.nlm.nih.gov/pubmed/30263038
http://dx.doi.org/10.1186/s12986-018-0297-4

Ejemplares similares